目次は見出しの階層(編・章・節・項…など)ごとに絞り込んで見ることができます。
… 資料編に詳細な情報があります。
目次項目 | ページ |
---|
HUMANITY, CHEMISTRY, AND OUR 100 YEARS / Jun Suzuki President and CEO,Representative Director of the Board | 巻頭 | |
---|---|---|
Part 1 The Age of Chemical Fibers 1904-1967 | 〔1〕 | |
Introduction Japan's First Artificial Silk Manufacturer 1904-1917 | p2 | |
Launching Viscose Research / Manufacturing Artificial Silk Using the Viscose Method / The Establishment of the Yonezawa Artificial Silk Yarn Manufacturing Plant | p2 | |
Chapter 1 The Birth of Teikoku Jinzo-Kenshi 1918-1932 | p6 | |
The Establishment of Teikoku Jinzo-Kenshi / Construction of the Hiroshima Plant / The Iwakuni Plant Comes On Line / Financial Panic and the Collapse of Suzuki Shoten / Expanding Rayon Output and the Start of Staple Fiber Production / The Yonezawa Plant Shuts Its Doors / Creating an Effective Sales Configuration / Operating Results (1918-1932) | p6 | |
Chapter 2 At the Forefront of the Rayon Industry 1933-1945 | p14 | |
1. Responding to Soaring Demand for Rayon and Expanding Production Capabilities | p14 | |
The Golden Era of Japan's Rayon Industry / Building the Mihara Plant / The Establishment of Daini Teikoku Jinken / Full-Scale Production of Rayon Staple Fiber and the Establishment of the Marifu Plant / Public Listing and the Teijin Incident | p14 | |
2. Increasingly Stringent Wartime Economic Controls | p18 | |
Wartime Company Restructurings / The Shift to Wartime Production / China Rayon and the Establishment of Teijin Aircraft Industry / The Deaths of Naokichi Kaneko and Itsuzo Hata | p18 | |
3. Overview of the Organization and Operating Results | p20 | |
Reorganization of the Company's Headquarters / Operating Results (1933-1945) | p20 | |
Chapter 3 The Recovery of the Rayon Business 1946-1953 | p22 | |
1. Postwar Recovery | p22 | |
The Atomic Bombing of Hiroshima / Restarting Production / The Dissolution of the Zaibatsu and Its Impact on Teikoku Jinzo-Kenshi / A New Salt Production Business and the Okunoshima Poison Gas Cleanup Operation / Shinzo Ohya Inaugurated as President / The Death of Seita Kumura / A New Headquarters Building / A Visit from the Emperor and the Launch of a New Company Song | p22 | |
2. Korean War-Related Special Procurement Demand and the Textiles Boom | p28 | |
From the Removal of Restrictions to Economic Prosperity / Production of High-Tenacity Rayon Filament / Building the Nagoya Plant and Bidding Farewell to the Hiroshima Plant / Operating a Woven Fabrics Plant / The Establishment of Teijin Shoji | p28 | |
3. Overview of the Organization and Operating Results | p32 | |
The Formation of Employee Unions / Teijin Scholarships / Operating Results (1946-1953) | p32 | |
Chapter 4 A Shift to Synthetic Fibers and the Expansion of Operations 1954-1967 | p34 | |
1. Structural Reforms in a Time of High Economic Growth | p34 | |
The Origins of the Japanese Economic Miracle / A Major Curtailment of Rayon Operations / Rayon Recession and a Voluntary Retirement Program / Shinzo Ohya Returns as President to Spearhead Restructuring / Formulating Long-Term Management Plans /Adopting a Divisional Structure / Enhancing R&D Capabilities / Relocation of Headquarters Functions to Tokyo and a New Name | p34 | |
2. Entering the Synthetic Fibers Business | p39 | |
Independent Acetate Research / Introducing Acetate Technology and Building the Matsuyama Plant / The Decline of Rayon and Research in the Area of Synthetic Fibers / Proprietary Synthetic Fibers Research / The In-House Invention of Teviron / Licensing In Polyester Technologies / Concluding a Licensing Agreement with ICI / Production of Tetoron Polyester Fibers Begins / Tetoron Marketing Launch / Expansion of Tetoron Production / Achieving Self-Sufficiency in DMT / Expansion into Aromatic Petrochemicals and Construction of the Tokuyama Plant / Acquisition of Nylon Technology / An Attempt to Commercialize Acrylic / Establishing an Overseas Presence / Fiber Processing and Finishing in Overseas Markets | p39 | |
3. Launching the Chemical Products Business | p53 | |
The Start of Polycarbonate Resin Production / Licensing In Polycarbonate Resin Technology from Bayer / Establishment of the Chemical Products Division / Entry into the Cellophane Business / The Beginnings of Teijin's PET Film Business | p53 | |
4. Overview of the Organization and Operating Results | p58 | |
Reform of the Personnel System / Operating Results (1954-1967) | p58 | |
Part 2 An Era of Diversification 1968-1990 | 〔61〕 | |
Chapter 1 Diversifying Operations 1968-1976 | p62 | |
1. The End of Japan's Postwar Economic Miracle and the Diversification of Operations | p62 | |
U.S.-Japan Textile Negotiations and the Dollar Shock / The First Oil Shock / Establishing the Future Development Division / Aiming for Net Sales of 2 Trillion / Creating the Comprehensive Action Committee and Appointing Roving Ambassadors / A New Osaka Headquarters Building | p62 | |
2. Growth of the Tetoron Business and Withdrawal from the Rayon Business | p66 | |
Construction of the Ehime Plant / Expanding the Overseas Fibers Business / Launching Polyester Polymerization and Yarn Production Outside Japan / Launching Polyester Weaving and Dyeing Operations Overseas / Licensing Out Production Technologies and Exporting Plants / Sowing the Seeds for Diverse New Synthetic Fibers Businesses / Downstream Expansion of the Fibers Business / Withdrawal from the Rayon Business | p66 | |
3. Expansion of the Chemical Products Business | p77 | |
A New Business Configuration / Increasing Production of Panlite Polycarbonate Resin / Commercializing FR-PET and PBT Resin / Full-Scale Commercialization of PET Film and Construction of the Gifu Plant / Entering and Exiting the PEN Film Business / The Flooding of the Gifu Plant | p77 | |
4. Expanding into the Pharmaceuticals Business | p81 | |
Establishing the Medical & Pharmaceutical Industries Division / Exploratory Initiatives / Investing in Daisan Pharmaceuticals / Establishing and Swiftly Withdrawing from Alcon-Teijin / Partnership with Boehringer Ingelheim / Dialyzer Development Efforts | p81 | |
5. Promoting Diversification | p85 | |
Entering the Petroleum Development Business / Expanding into Food Products / Expanding into the Lifestyle Arena / Expanding into the Information Sector / Other Diversification Efforts | p85 | |
6. Overview of the Organization and Operating Results | p92 | |
Deployment of New Systems / Construction of the Fuji Institute of Education & Training / Establishing a Monument to the Birthplace of the Artificial Fibers Industry / Operating Results (1968-1976) / From Diversification to Liquidation | p92 | |
Chapter 2 A Change of Direction: From Expanding Operations to Growing New Businesses 1977-1990 | p96 | |
1. Deteriorating Results and a State of Emergency | p96 | |
From Endaka Recession to the Bubble Economy / A State of Emergency / Resolving to Implement a Radical Rationalization Plan / Reinstating a Function-Specific Divisional Configuration / The Death of Shinzo Ohya / Tomoo Tokusue Takes Control / A New Long-Term Management Plan and Efforts to Strengthen the Policy Board / Formulation of a Medium-Term Management Plan and a New Business Division Configuration / The Appointment of Sashiro Okamoto / Hiroshi Itagaki Takes Office / An Overall Reorganization and the Absorption of Teijin Acetate | p96 | |
2. The Reorganization of the Fibers Business | p102 | |
Withdrawal from Overseas Fibers Businesses / Consolidation and Integration of Domestic Fibers Businesses / The Debut of Milpa and the Shingosen Boom / The Growth of New High-Performance Synthetic Fibers | p102 | |
3. The Expansion of the Films and Plastics Business | p107 | |
Development of Polycarbonate Resin for CDs and the Rapid Advance of Sales / Entry into the Market for PET Resin for Bottles / Emphasis on Film for Magnetic Applications / Moving into the Floppy Disk Business / Reinforcing the Film Processing Business / Revival of the PEN Film Business | p107 | |
4. Steady Expansion of the Pharmaceuticals Business | p112 | |
Establishing and Absorbing Teijin Pharmaceutical / The Launch of Venilon: Teijin's First Unique Proprietary Drug / Launching Onealfa as the Next Proprietary Drug / Bringing In New Drugs from Boehringer Ingelheim / Creating a Pharmaceuticals Production Configuration / The Start of Outsourced Sales / The Search for Next-Generation Products / Promoting Advanced Research / Introducing Alendronate / Research in Structural Modification and New Dosage Forms / Licensing Out Technologies and Products to Overseas Companies / Expanding into the Dialyzer Business / Entry into the Clinical Laboratory Testing Field / Diversifying into Diagnostic Drugs | p112 | |
5. Inaugurating the Home Healthcare Business | p125 | |
Developing a Membrane Oxygen Concentrator / Authorization of HOT for NHI Coverage and the Creation of an Independent Business Model / Introducing an Adsorption-Type Oxygen Concentrator / Establishing a Proper Oxygen Concentrator Production Configuration | p125 | |
6. Expanding into the Petroleum-Related Equipment Business | p128 | |
Entering Oil Well Pipe-Related Businesses / Developing Anchors for Use in Civil Engineering and Construction / Spinning Off Headquarters Functions | p128 | |
7. Overview of the Organization and Operating Results | p130 | |
Extension of the Mandatory Retirement Age and Overhaul of the Personnel System / Operating Results (1977-1990) | p130 | |
Part 3 The Epoch of New Value Creation 1991-2018 | 〔133〕 | |
Chapter 1 Building a Framework for Profitable Growth 1991-2000 | p134 | |
1. The Road to Revitalization | p134 | |
The Collapse of the Bubble and a Prolonged Economic Slump / Inaugurating of the Revitalization Project / Setting Forth the Corporate Philosophy and Implementing Revitalization Measures / A New Long-Term Management Plan | p134 | |
2. Toward Profitable Growth | p137 | |
A New Management Team Takes the Reins / The Launch of the Forward 2000 Medium-Term Management Plan / Improving the Efficiency of Head Office Functions and Delegating Authority / The Creation of a Chief Officer System | p137 | |
3. Promoting CSR | p139 | |
Governance Reform / A New Risk Management and Compliance Framework / Environmental Management Initiatives | p139 | |
4. The Resurgence of the Polyester Fibers Business | p142 | |
The Million-Tonne Vision / The Second Global Push for the Fibers Business / Spinning Off the Nylon Fibers Business | p142 | |
5. Growing the High-Performance Fibers Business | p146 | |
Advancing into Carbon Fibers /Adding Twaron to the Teijin Portfolio / Expanding the Technora Business / Diversifying into the Meta-Aramid Paper Business | p146 | |
6. Efforts to Strengthen Trading Company Capabilities | p149 | |
The Birth of N.I. Teijin Shoji / Developing a Fashion Brand Business | p149 | |
7. Globalization of the Plastics Business | p151 | |
Creating a Global Production Configuration for Polycarbonate Resin / An Expanded Global Resins Sales Network / Reinforcing Resin-Related R&D / Restructuring the PBT and FR-PET Businesses | p151 | |
8. Evolution into a Global Player in the Films Business | p153 | |
Establishing Joint Ventures with DuPont / Expanding Global PET Films Joint Ventures / Reinforcing the Operating Foundations of the Films Business / Responding to Demand for PET Film for New Applications / The Growth of the PEN Film Business / Commercializing Film for LCDs | p153 | |
9. Establishing a Direct Sales Configuration for Pharmaceuticals | p158 | |
Setting Up Direct Sales Nationwide / Launching Bonalfa: Teijin's First New Proprietary Drug in 13 Years | p158 | |
10. R&D and the Discovery of New Drugs | p159 | |
Research in the Area of Small Molecule Drug Discovery / The Development of TMX-67 / Overhauling the Research Framework / Creating a New Drug Development Configuration / A Pipeline Strategy Integrating In-House Development and Licensed-In Products / Providing Added Value: Expanded Indications and New Dosage Forms / Licensing Out Proprietary Drugs: Laying the Groundwork for the Globalization of TMX-67 | p159 | |
11. Withdrawal from Peripheral Businesses | p162 | |
12. Entering New Areas in the Home Healthcare Field | p163 | |
An Expanded Sales Configuration / New Home Healthcare Equipment / Patient Support in the Aftermath of the Great Hanshin Earthquake / A New Challenge: The Personal Dialysis Market / Strengthening the Research Configuration and Business Development Efforts | p163 | |
13. The Birth of Infocom | p167 | |
Teijin Systems Technology: The Synthetic Fibers Industry's First Software Development and Sales Company / Infocom: Nissho lwai's Systems Development and Services Subsidiary / The Merger of Teijin Systems Technology and lnfocom | p167 | |
14. Chlorofluorocarbon Alternatives, Composite Materials and Recording Media | p168 | |
The Challenge of Eliminating Chlorofluorocarbons / Forays into Composite Materials / Exploring Opportunities in the Recording Media Business | p168 | |
15. Overview of the Organization and Operating Results | p171 | |
The Revision of Key Systems / Operating Results (1991-2000) / Realignment of Financing Subsidiaries | p171 | |
Chapter 2 Advancing Group and Global Management 2001-2007 | p174 | |
1. Strengthening Group Management | p174 | |
Japan's Longest Post-War Economic Boom /A New Management Team / Adopting a Holding Company System / Rebuilding and Augmenting Overall Profitability / Promoting Business Reforms to Achieve Innovative Growth / Putting Down Firmer Roots in Promising Markets / Reinforcing R&D Capabilities / Building a Stronger Corporate Brand / Efficient Asset Management through Reduction and Effective Use | p174 | |
2. Adding Depth to CSR Initiatives | p180 | |
Building a Stronger CSR Framework / Encouraging Environmental Management / Launch of Chemical Recycling | p180 | |
3. Results Growth Driven by High-Performance Fibers | p184 | |
Expanding the Aramid Fibers Business / A New Brand and Expanded Global Bases for Carbon Fibers / Emergence of Carbon Fiber Cartels | p184 | |
4. Rebuilding the General-Purpose Fibers Business | p186 | |
Reforming the Polyester Fibers for Apparel Business / Strategic Moves by Teijin Fibers / Withdrawal from Unprofitable Fibers Businesses / Transforming N.I. Teijin Shoji into a Wholly Owned Subsidiary | p186 | |
5. Advancing the Resins Business Worldwide | p190 | |
Polycarbonate Resin Production in the PRC / Enhancing Molding Technologies / Carbon Monoxide Leak and Efforts to Enhance Workplace Safety / Expanding Resin Production and Sales | p190 | |
6. Bolstering the PET and PEN Films Businesses | p192 | |
Reinforcing Films Production and Sales Capabilities | p192 | |
7. Launch of Bonalon and Sustained Growth in the Pharmaceuticals Business | p194 | |
Proposal for Business Integration with Kyorin Pharmaceutical / Bonalon: Unveiling a New Major Drug | p194 | |
8. Promoting R&D in the Area of Pharmaceuticals | p195 | |
A New Emphasis on Clinical Development / Capitalizing On Licensing-In Arrangements to Introduce New Drugs / Providing Value by Expanding Indications and Adding New Dosage Forms / Cultivating Overseas Markets | p195 | |
9. Taking On New Challenges: Broadening the New Home Healthcare Business | p198 | |
Expanding the HOT Business by Accepting Consignment Orders and Making Key Acquisitions / Recall of a Core Device | p198 | |
10. Expanding the Scope of the IT Business | p200 | |
Launching GRANDIT / Introducing E-Book Distribution Services / Flagging Results and a Swift Recovery | p200 | |
11. Diversification into Battery Materials and Environmental Solutions | p202 | |
Entering the Market for Battery Materials / Expanding Environmental Businesses | p202 | |
12. Overview of the Organization and Operating Results | p204 | |
Amendments to the Personnel System / Operating Results (2001-2007)/Reform Measures in Noncore Businesses / Delisting and the Introduction of Hostile Takeover Defense Measures /A New Group Song | p204 | |
Chapter 3 Structural Reforms and Portfolio Transformation 2008-2018 | p208 | |
1. Embarking on a New Growth Trajectory | p208 | |
A Global Economic Slump / Shigeo Ohyagi Becomes President / A Second State of Emergency / Formulating Basic Management Policies for the Teijin Group / A New Medium- to Long-Term Management Vision: CHANGE for 2016 / Organizational Changes to Facilitate a Solutions-Oriented Business Model / Jun Suzuki Takes Over as President / Revising CHANGE for 2016 / ALWAYS EVOLVING: Toward Realization of the Teijin Group's Long-Term Vision / An Updated Corporate Organization Centered on Materials and Healthcare Businesses | p208 | |
2. Reinforcing CSR | p215 | |
An Updated CSR Policy and the Promotion of Related Initiatives / Scaling Back the Recycling Business / Responding to the Great East Japan Earthquake / Relocating the Tokyo and Osaka Head Offices | p215 | |
3. Polyester Fibers: Shifting Expansion Strategies | p218 | |
Downsizing the Polyester Fibers Business / Exiting the Polyester Raw Materials Business / The Dissolution of Teijin Fibers / Establishing Teijin Frontier / Demise of the Expansion Strategy for General-Purpose Polyester Fibers | p218 | |
4. High-Performance Fibers: Reinforcing the Aramid Fibers and Carbon Fibers Businesses | p221 | |
Further Strengthening the Aramid Fibers Business / From Struggles to Renewed Expansion in the Carbon Fibers Business / Evolution of Downstream Carbon Fibers Businesses / Diversifying into Materials for Aerospace Applications / Renaming Teijin Group Carbon Fibers Companies | p221 | |
5. Plastics: Realigning Businesses and Extending Downstream Solutions | p224 | |
Shifting to a Solutions-Oriented Business Model / Developing Downstream Polycarbonate Resins Businesses / Bolstering Sales of Polycarbonate Resin for LCDs and Touchscreens / Revamping the Overseas Polycarbonate Resin Production Configuration / Withdrawal from Fumigants, PET Resin for Beverage Bottles and PBT / Diversifying into New High-Performance Resins Businesses | p224 | |
6. Films: A Shift in Focus to Asia | p227 | |
Responding to Growing Demand for PET Film for New Applications / Developing New Technologies and Applications to Create New Markets / Relocating Production to Asia | p227 | |
7. Pharmaceuticals: The Launch and Global Deployment of Febuxostat | p229 | |
The Debut of Feburic / Global Sales of Febuxostat | p229 | |
8. Accelerating Pharmaceuticals R&D | p231 | |
Drug Development Efforts Centered on Early-Stage Joint Research / Licensing In New Drugs / Adding Value by Expanding Indications and Dosage Forms | p231 | |
9. Home Healthcare: Globalization and the Promotion of New Businesses | p234 | |
Launching Home Healthcare Services Overseas / Establishing a Medical Device Production Configuration in the PRC / Cultivating Domestic Demand in the Area of Respiratory Disease / New Directions in Home Healthcare | p234 | |
10. IT: The Growth of Infocom | p240 | |
IT Solutions: A Renewed Focus on Healthcare / Digital Entertainment: Augmenting and Strengthening E-comic Distribution Services / Strategies for Creating New IT Businesses / Terminating Shin-Yokohama Data Center Services / An Increased Stake in Infocom | p240 | |
11. New Businesses: Emphasis on the Materials and Healthcare Sectors | p241 | |
Adding Depth to Composite Materials / Developing New Healthcare Businesses / Commercializing LIB Separators / Launch of the High-Performance MIRAIM Membrane / Efforts to Commercialize Products in Overlapping Areas | p241 | |
12. Overview of the Organization and Operating Results | p247 | |
Revisions to Key Human Resources Systems / Operating Results (2008-2018) | p247 | |
Chapter 4 The Road to Future Value Creation: Ceaseless Evolution and Ambition 2018- | p252 | |
Creating Future Value / Stepping Up Growth and Transformation Strategies / Ceaseless Evolution and Ambition: The Next 100 Years | p252 | |
Appendix | 〔255〕 | |
1. Our Philosophy | p257 | |
Corporate Philosophy / Brand Statement / Long-term Vision / Code of Conduct | p257 | |
2. Articles of Incorporation | p260 | |
3. 100 Years of Leadership: Teijin's Presidents | p263 | |
4. Corporate Governance Guide | p264 | |
5. CSR | p268 | |
CSR Basic Policy / Teijin Group Global Environmental Charter / Teijin Group Human Rights Policy | p268 | |
Editorial Notes | p270 |
- 索引リスト
-